ArticleNature communications2026

Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes.

Chih-Lang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.